2 Markers of Parkinson’s Progression May Help Trials in Newly Diagnosed Patients, Study Says

2 Markers of Parkinson’s Progression May Help Trials in Newly Diagnosed Patients, Study Says
Clinical trials in patients with early stage Parkinson’s may benefit from assessing markers of disease progression — namely, changes in the Movement Disorder Society (MDS)-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and dopamine transporter imaging, according to five-year results in a major observational study. The study, “Longitudinal Change of Clinical and Biological Measures in Early Parkinson’s Disease: Parkinson’s Progression Markers Initiative ... read more
Source: Parkinson’s News TodayPublished on 2018-04-11By Patricia Inacio, PhD